ArticleScientific reports2026

CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4.

Shiho Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.